News
June brought major blood cancer updates, and CURE is sharing the latest in myelofibrosis treatment and FDA breakthroughs, as ...
CURE connects oncology patients, survivors, and caregivers with expert guidance, cancer updates, treatment education, and ...
Advocates for veterans are championing Assembly Bill 1103, which would fast-track the approval of academic studies on ...
Amylyx Pharmaceuticals Inc. (NASDAQ:AMLX) is one of the best biotech stocks to invest in now. On June 3, Amylyx ...
Healthy volunteers were given either ISLA-101 or a placebo, then deliberately exposed to a weakened strain of dengue virus.
2dOpinion
MedPage Today on MSNHow Fast Is Too Fast for FDA Drug Review?But a deeper look reveals that some elements of the program are so aligned with "common sense" that FDA has already been ...
FNP-223 is currently being investigated in a phase 2 trial evaluating the treatment in adults with possible or probable PSP-Richardson syndrome.
The FDA announced a new national priority voucher plan that aims to cut drug review times, while Headspace launches direct-to ...
Scientists are to examine whether drugs that are already in use could be repurposed to treat the symptoms of both Alzheimer’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results